Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,550 | 16 | 84.0% |
| Food and Beverage | $1,775 | 48 | 10.2% |
| Travel and Lodging | $1,003 | 5 | 5.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| TESARO, Inc. | $14,017 | 29 | $0 (2019) |
| GlaxoSmithKline, LLC. | $1,950 | 3 | $0 (2021) |
| Medtronic, Inc. | $417.12 | 3 | $0 (2024) |
| Clovis Oncology, Inc. | $230.74 | 3 | $0 (2018) |
| INTUITIVE SURGICAL, INC. | $203.29 | 8 | $0 (2024) |
| Teleflex Medical Incorporated | $90.35 | 1 | $0 (2017) |
| Foundation Medicine, Inc. | $57.37 | 3 | $0 (2017) |
| Merck Sharp & Dohme LLC | $52.72 | 3 | $0 (2024) |
| Rigel Pharmaceuticals, Inc. | $48.03 | 2 | $0 (2023) |
| GENZYME CORPORATION | $37.53 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $385.90 | 13 | INTUITIVE SURGICAL, INC. ($166.53) |
| 2023 | $468.04 | 9 | Medtronic, Inc. ($306.32) |
| 2022 | $53.88 | 3 | GENZYME CORPORATION ($37.53) |
| 2021 | $673.25 | 2 | GlaxoSmithKline, LLC. ($650.00) |
| 2020 | $1,300 | 2 | GlaxoSmithKline, LLC. ($1,300) |
| 2019 | $5,619 | 14 | TESARO, Inc. ($5,605) |
| 2018 | $5,508 | 17 | TESARO, Inc. ($5,392) |
| 2017 | $3,319 | 9 | TESARO, Inc. ($3,019) |
All Payment Transactions
69 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/19/2024 | Takeda Pharmaceuticals U.S.A., Inc. | FRUZAQLA (Drug) | Food and Beverage | In-kind items and services | $21.12 | General |
| Category: ONCOLOGY | ||||||
| 10/24/2024 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | In-kind items and services | $29.18 | General |
| Category: Oncology | ||||||
| 08/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $18.61 | General |
| Category: SURGERY | ||||||
| 08/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: SURGERY | ||||||
| 08/06/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $8.67 | General |
| Category: SURGERY | ||||||
| 07/24/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $18.45 | General |
| Category: ONCOLOGY | ||||||
| 02/06/2024 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2024 | Mirati Therapeutics, Inc. | KRAZATI (Drug) | Food and Beverage | Cash or cash equivalent | $24.83 | General |
| Category: Oncology | ||||||
| 01/30/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $55.92 | General |
| Category: SURGERY | ||||||
| 01/29/2024 | Medtronic, Inc. | TRUCLEAR (Device) | Food and Beverage | In-kind items and services | $110.80 | General |
| Category: Hysteroscopy Systems | ||||||
| 01/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $23.99 | General |
| Category: SURGERY | ||||||
| 01/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $21.14 | General |
| Category: SURGERY | ||||||
| 01/09/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $20.66 | General |
| Category: SURGERY | ||||||
| 12/12/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $25.48 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 11/08/2023 | EMD Serono, Inc. | BAVENCIO (Drug) | Food and Beverage | Cash or cash equivalent | $25.03 | General |
| Category: Oncology | ||||||
| 08/31/2023 | Stemline Therapeutics Inc. | Orserdu (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Oncology | ||||||
| 08/22/2023 | Intuitive Surgical, Inc. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $36.76 | General |
| Category: SURGERY | ||||||
| 08/22/2023 | Rigel Pharmaceuticals, Inc. | Rezlidhia (Drug), Tavalisse | Food and Beverage | Cash or cash equivalent | $22.55 | General |
| Category: Acute Myeloid Leukemia | ||||||
| 08/01/2023 | Merck Sharp & Dohme LLC | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.28 | General |
| Category: ONCOLOGY | ||||||
| 07/26/2023 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ONCOLOGY | ||||||
| 06/01/2023 | Medtronic, Inc. | SIGNIA (Device) | Food and Beverage | In-kind items and services | $124.95 | General |
| Category: Surgical Stapling | ||||||
| 05/23/2023 | Medtronic, Inc. | TRUCLEAR (Device) | Food and Beverage | In-kind items and services | $181.37 | General |
| Category: Hysteroscopy Systems | ||||||
| 08/08/2022 | GENZYME CORPORATION | JEVTANA (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Oncology | ||||||
| 06/28/2022 | JAZZ PHARMACEUTICALS INC. | ZEPZELCA (Drug), VYXEOS | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 04/26/2022 | GENZYME CORPORATION | LIBTAYO (Biological), LIBTAYO, LIBTAYO | Food and Beverage | In-kind items and services | $14.10 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 254 | 293 | $184,520 | $43,642 |
| 2022 | 5 | 192 | 222 | $120,915 | $31,133 |
| 2021 | 6 | 124 | 141 | $78,459 | $23,285 |
| 2020 | 1 | 11 | 11 | $3,333 | $1,492 |
All Medicare Procedures & Services
20 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2023 | 25 | 25 | $89,925 | $19,414 | 21.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $26,712 | $6,328 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 87 | $22,533 | $5,870 | 26.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 37 | 44 | $16,192 | $4,826 | 29.8% |
| 38900 | Imaging of lymph nodes during surgery | Facility | 2023 | 16 | 16 | $12,976 | $2,790 | 21.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $9,390 | $2,642 | 28.1% |
| 58100 | Biopsy of lining of uterus | Office | 2023 | 18 | 18 | $6,372 | $1,478 | 23.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 30 | 35 | $420.00 | $294.00 | 70.0% |
| 58571 | Removal of uterus, tubes, and/or ovaries through abdomen using an endoscope, 250.0 g or less | Facility | 2022 | 17 | 17 | $58,584 | $13,091 | 22.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 69 | 69 | $33,720 | $9,800 | 29.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 50 | 69 | $17,247 | $5,059 | 29.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 31 | $10,958 | $3,075 | 28.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 36 | $406.00 | $106.56 | 26.2% |
| 58571 | Abdominal removal of uterus (250 grams or less) with removal of tubes and/or ovaries using an endoscope | Facility | 2021 | 14 | 14 | $48,274 | $10,692 | 22.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 36 | 36 | $12,502 | $4,935 | 39.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $7,530 | $3,293 | 43.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 17 | 22 | $4,813 | $2,296 | 47.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 21 | 28 | $5,079 | $1,997 | 39.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 19 | 24 | $262.00 | $72.00 | 27.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 11 | 11 | $3,333 | $1,492 | 44.8% |
About Dr. David Doo, MD
Dr. David Doo, MD is a Gynecologic Oncology healthcare provider based in Birmingham, Alabama. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1386087559.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Doo, MD has received a total of $17,328 in payments from pharmaceutical and medical device companies, with $385.90 received in 2024. These payments were reported across 69 transactions from 21 companies. The most common payment nature is "Consulting Fee" ($14,550).
As a Medicare-enrolled provider, Doo has provided services to 581 Medicare beneficiaries, totaling 667 services with total Medicare billing of $99,552. Data is available for 4 years (2020–2023), covering 20 distinct procedure/service records.
Practice Information
- Specialty Gynecologic Oncology
- Other Specialties Gynecologic Oncology
- Location Birmingham, AL
- Active Since 04/08/2013
- Last Updated 04/24/2020
- Taxonomy Code 207VX0201X
- Entity Type Individual
- NPI Number 1386087559
Products in Payments
- ZEJULA (Drug) $1,444
- TRUCLEAR (Device) $292.17
- Rubraca (Drug) $230.74
- Da Vinci Surgical System (Device) $203.29
- SIGNIA (Device) $124.95
- Access Solutions: Weck brand (Device) $90.35
- FOUNDATIONONE (Device) $57.37
- KEYTRUDA (Biological) $52.72
- Rezlidhia (Drug) $48.03
- Lenvima (Drug) $29.18
- BAVENCIO (Drug) $25.03
- KRAZATI (Drug) $24.83
- JEVTANA (Drug) $23.43
- LYNPARZA (Drug) $23.25
- FRUZAQLA (Drug) $21.12
- Orserdu (Drug) $18.41
- ZEPZELCA (Drug) $16.35
- SUBSYS (Drug) $14.64
- VENCLEXTA (Drug) $14.21
- LIBTAYO (Biological) $14.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gynecologic Oncology Doctors in Birmingham
Dr. Rebecca Arend, M.d, M.D
Gynecologic Oncology — Payments: $110,102
Charles Leath
Gynecologic Oncology — Payments: $95,850
Warner Huh, Md, MD
Gynecologic Oncology — Payments: $88,407
Dr. Wesley Burkett, M.d, M.D
Gynecologic Oncology — Payments: $1,998
Jaclyn Wall, M.d, M.D
Gynecologic Oncology — Payments: $1,486
Margaret Liang
Gynecologic Oncology — Payments: $1,340